
Sign up to save your podcasts
Or


This is a discussion on the recent CREDENCE trial for canagliflozin in diabetics with nephropathy.
By Dr Casey Parker4.8
55 ratings
This is a discussion on the recent CREDENCE trial for canagliflozin in diabetics with nephropathy.

26,197 Listeners

1,866 Listeners

545 Listeners

5 Listeners

260 Listeners

307 Listeners

1,807 Listeners